Full Report

Format

Full Report
Summary (Text)
Summary (XML)

Send to:

Choose Destination

File
Clipboard
Collections

Mature T-cell and NK-cell non-Hodgkin lymphoma

MedGen UID:: 1790498
•Concept ID:: C5551485
•: Neoplastic Process

Synonyms:	Mature T-and NK-Cell Lymphoma; mature T-and NK-cell lymphoma; mature T-cell and natural killer cell lymphoma; Mature T-Cell and NK-Cell Lymphoma; mature T-cell and NK-cell lymphoma; Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma; mature T-cell and NK-cell non-Hodgkin lymphoma; Mature T-Cell and NK-Cell Non-Hodgkin's Lymphoma; mature T-cell and NK-cell non-Hodgkin's lymphoma; mature T-cell lymphoma; Mature T-Cell Non-Hodgkin's Lymphoma; mature T-cell non-Hodgkin's lymphoma; NK-T cell lymphoma; Peripheral T-Cell Lymphoma; peripheral T-cell lymphoma; PTCL

Monarch Initiative:	MONDO:0000430

Definition

This type of lymphoma is not frequently seen in the western hemisphere. Clinically, with the exception of anaplastic large cell lymphoma, mature T- and NK-cell lymphomas are among the most aggressive of all hematopoietic neoplasms. Representative disease entities include mycosis fungoides, angioimmunoblastic T-cell lymphoma, hepatosplenic T-cell lymphoma, and anaplastic large cell lymphoma. [from NCI]

Term Hierarchy

GTR
MeSH

CClinical test, RResearch test, OOMIM, GGeneReviews, VClinVar

CROGVMature T-cell and NK-cell non-Hodgkin lymphoma

Hematopoietic and Lymphoid System Disorder
- Hematologic disorder
  - Hematopoietic and lymphoid cell neoplasm
    - Lymphoid neoplasm
      - T-cell and NK-cell neoplasm
        Neoplasm of mature T-cells or NK-cells
        Mature T-cell and NK-cell non-Hodgkin lymphoma
        Anaplastic large cell lymphoma
        Adult anaplastic large cell lymphoma
        Adult Primary Cutaneous Anaplastic Large Cell Lymphoma
        Adult Systemic Anaplastic Large Cell Lymphoma
        Advanced Anaplastic Large Cell Lymphoma
        ALK-negative anaplastic large cell lymphoma
        Breast implant-associated anaplastic large cell lymphoma
        Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative
        Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Negative
        ALK-positive anaplastic large cell lymphoma
        Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive
        Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Positive
        Anaplastic Large Cell Lymphoma, Giant Cell Rich Subtype
        Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype
        Anaplastic Large Cell Lymphoma, Signet Ring-Like Subtype
        Central nervous system anaplastic large cell lymphoma
        Childhood anaplastic large cell lymphoma
        Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma
        Childhood Systemic Anaplastic Large Cell Lymphoma
        Noncutaneous Childhood Anaplastic Large Cell Lymphoma by Ann Arbor Stage
        Recurrent Childhood Anaplastic Large Cell Lymphoma
        Common Variant Anaplastic Large Cell Lymphoma
        Localized Anaplastic Large Cell Lymphoma
        Lymphohistiocytic Variant Anaplastic Large Cell Lymphoma
        Noncutaneous Anaplastic Large Cell Lymphoma by Ann Arbor Stage
        Ann Arbor Stage I Noncutaneous Anaplastic Large Cell Lymphoma
        Ann Arbor Stage II Noncutaneous Anaplastic Large Cell Lymphoma
        Ann Arbor Stage III Noncutaneous Anaplastic Large Cell Lymphoma
        Ann Arbor Stage IV Noncutaneous Anaplastic Large Cell Lymphoma
        Primary cutaneous anaplastic large cell lymphoma
        Recurrent Primary Cutaneous Anaplastic Large Cell Lymphoma
        Refractory Primary Cutaneous Anaplastic Large Cell Lymphoma
        Recurrent Anaplastic Large Cell Lymphoma
        Recurrent Breast Implant-Associated Anaplastic Large Cell Lymphoma
        Recurrent Systemic Anaplastic Large Cell Lymphoma
        Refractory Anaplastic Large Cell Lymphoma
        Refractory Breast Implant-Associated Anaplastic Large Cell Lymphoma
        Refractory Systemic Anaplastic Large Cell Lymphoma
        Small cell variant anaplastic large cell lymphoma
        Systemic Anaplastic Large Cell Lymphoma
        Central Nervous System Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
        Childhood Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
        Childhood Nasal Type Extranodal NK/T-Cell Lymphoma
        Systemic EBV-Positive T-Cell Lymphoma of Childhood
        Extranodal nasal NK/T cell lymphoma
        Adult Nasal Type Extranodal NK/T-Cell Lymphoma
        Cutaneous Nasal Type Extranodal NK/T-Cell Lymphoma
        Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage
        Ann Arbor Stage I Nasal Type NK/T-Cell Lymphoma
        Ann Arbor Stage II Nasal Type NK/T-Cell Lymphoma
        Ann Arbor Stage III Nasal Type NK/T-Cell Lymphoma
        Ann Arbor Stage IV Nasal Type NK/T-Cell Lymphoma
        Recurrent Nasal Type Extranodal NK/T-Cell Lymphoma
        Refractory Nasal Type Extranodal NK/T-Cell Lymphoma
        Sinonasal Extranodal NK/T-Cell Lymphoma
        Nasal Cavity Extranodal NK/T-Cell Lymphoma
        Testicular Nasal Type Extranodal NK/T-Cell Lymphoma
        Hepatosplenic T-cell lymphoma
        Recurrent Hepatosplenic T-Cell Lymphoma
        Refractory Hepatosplenic T-Cell Lymphoma
        Indolent T-Cell Non-Hodgkin Lymphoma
        Mycosis fungoides
        Mycosis Fungoides by AJCC v7 Stage
        Pagetoid Reticulosis
        Recurrent Mycosis Fungoides
        Refractory Mycosis Fungoides
        Transformed Mycosis Fungoides
        Mycosis fungoides variant
        Folliculotropic mycosis fungoides
        Granulomatous slack skin disease
        Subcutaneous panniculitis-like T-cell lymphoma
        Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma
        Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma
        Intestinal T-Cell Lymphoma
        Enteropathy-associated T-cell lymphoma
        Enteropathy-Associated T-Cell Lymphoma by Ann Arbor Stage
        Recurrent Enteropathy-Associated T-Cell Lymphoma
        Refractory Enteropathy-Associated T-Cell Lymphoma
        Small intestinal enteropathy-associated T-cell lymphoma
        Intestinal T-Cell Lymphoma, Not Otherwise Specified
        Monomorphic epitheliotropic intestinal T-cell lymphoma
        Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
        Refractory Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
        Small Intestinal Monomorphic Epitheliotropic T-Cell Lymphoma
        Leukemia-Lymphoma, Adult T-Cell
        Acute Adult T-Cell Leukemia/Lymphoma
        Adult T-Cell Leukemia/Lymphoma by Ann Arbor Stage
        Ann Arbor Stage I Adult T-Cell Leukemia/Lymphoma
        Ann Arbor Stage II Adult T-Cell Leukemia/Lymphoma
        Ann Arbor Stage III Adult T-Cell Leukemia/Lymphoma
        Ann Arbor Stage IV Adult T-Cell Leukemia/Lymphoma
        Chronic Adult T-Cell Leukemia/Lymphoma
        Cutaneous Adult T-Cell Leukemia/Lymphoma
        Hodgkin-Like Adult T-Cell Leukemia/Lymphoma
        Lymphomatous Adult T-Cell Leukemia/Lymphoma
        Recurrent Adult T-Cell Leukemia/Lymphoma
        Refractory Adult T-Cell Leukemia/Lymphoma
        Smoldering Adult T-Cell Leukemia/Lymphoma
        Mature T- and NK-Cell Lymphoma by Ann Arbor Stage
        Angioimmunoblastic T-Cell Lymphoma by Ann Arbor Stage
        Ann Arbor Stage I Angioimmunoblastic T-Cell Lymphoma
        Ann Arbor Stage II Angioimmunoblastic T-Cell Lymphoma
        Ann Arbor Stage III Angioimmunoblastic T-Cell Lymphoma
        Ann Arbor Stage IV Angioimmunoblastic T-Cell Lymphoma
        Ann Arbor Stage I Mature T- and NK-Cell Lymphoma
        Ann Arbor Stage I Enteropathy-Associated T-Cell Lymphoma
        Ann Arbor Stage II Mature T- and NK-Cell Lymphoma
        Ann Arbor Stage II Enteropathy-Associated T-Cell Lymphoma
        Ann Arbor Stage III Mature T- and NK-Cell Lymphoma
        Ann Arbor Stage III Enteropathy-Associated T-Cell Lymphoma
        Ann Arbor Stage IV Mature T- and NK-Cell Lymphoma
        Ann Arbor Stage IV Enteropathy-Associated T-Cell Lymphoma
        Methotrexate-Associated Peripheral T-Cell Lymphoma
        Mycosis Fungoides and Sezary Syndrome
        Mycosis Fungoides and Sezary Syndrome by AJCC v7 Stage
        Stage I Mycosis Fungoides and Sezary Syndrome AJCC v7
        Stage II Mycosis Fungoides and Sezary Syndrome AJCC v7
        Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7
        Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v7
        Mycosis Fungoides and Sezary Syndrome by AJCC v8 Stage
        Stage I Mycosis Fungoides and Sezary Syndrome AJCC v8
        Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8
        Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8
        Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8
        Recurrent Mycosis Fungoides and Sezary Syndrome
        Recurrent Sezary Syndrome
        Refractory Mycosis Fungoides and Sezary Syndrome
        Refractory Sezary Syndrome
        Sezary syndrome
        NK-Cell Lymphoma, Unclassifiable
        Recurrent NK-Cell Lymphoma, Unclassifiable
        Refractory NK-Cell Lymphoma, Unclassifiable
        Nodal Peripheral T-Cell Lymphoma of T Follicular Helper Cell Origin
        Angioimmunoblastic T-cell lymphoma
        Cutaneous Angioimmunoblastic T-Cell Lymphoma
        Recurrent Angioimmunoblastic T-Cell Lymphoma
        Refractory Angioimmunoblastic T-Cell Lymphoma
        Follicular T-Cell Lymphoma
        Recurrent Follicular T-Cell Lymphoma
        Refractory Follicular T-Cell Lymphoma
        Nodal Peripheral T-Cell Lymphoma with TFH Phenotype
        Recurrent Nodal Peripheral T-Cell Lymphoma with TFH Phenotype
        Refractory Nodal Peripheral T-Cell Lymphoma with TFH Phenotype
        Peripheral T-cell lymphoma
        Lymphoepithelioid Variant Peripheral T-Cell Lymphoma
        Primary EBV-Positive Nodal T-Cell or NK-Cell Lymphoma
        Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified
        Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified
        Peripheral T-Cell Lymphoma, Unclassifiable
        Primary cutaneous T-cell lymphoma
        Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
        Early Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
        Lymphomatoid papulosis
        Lymphomatoid Papulosis with DUSP22-IRF4 Gene Rearrangement
        Type A Lymphomatoid Papulosis
        Type B Lymphomatoid Papulosis
        Type C Lymphomatoid Papulosis
        Type D Lymphomatoid Papulosis
        Type E Lymphomatoid Papulosis
        Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype
        Primary Cutaneous Acral CD8-Positive T-Cell Lymphoma
        Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma
        Primary cutaneous gamma-delta t-cell lymphoma
        Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
        Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
        Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
        Recurrent Transformed T-cell Non-Hodgkin Lymphoma
        Recurrent Transformed Mycosis Fungoides
        Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
        Refractory Transformed T-cell Non-Hodgkin Lymphoma
        Refractory Transformed Mycosis Fungoides

Professional guidelines

PubMed

T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.

Horwitz SM, Ansell S, Ai WZ, Barnes J, Barta SK, Brammer J, Clemens MW, Dogan A, Foss F, Ghione P, Goodman AM, Guitart J, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Jones A, Kallam A, Kim YH, Kumar K, Mehta-Shah N, Olsen EA, Rajguru SA, Rozati S, Said J, Shaver A, Shea L, Shinohara MM, Sokol L, Torres-Cabala C, Wilcox R, Wu P, Zain J, Dwyer M, Sundar H
J Natl Compr Canc Netw 2022 Mar;20(3):285-308. doi: 10.6004/jnccn.2022.0015. PMID: 35276674

Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report.

Cook LB, Fuji S, Hermine O, Bazarbachi A, Ramos JC, Ratner L, Horwitz S, Fields P, Tanase A, Bumbea H, Cwynarski K, Taylor G, Waldmann TA, Bittencourt A, Marcais A, Suarez F, Sibon D, Phillips A, Lunning M, Farid R, Imaizumi Y, Choi I, Ishida T, Ishitsuka K, Fukushima T, Uchimaru K, Takaori-Kondo A, Tokura Y, Utsunomiya A, Matsuoka M, Tsukasaki K, Watanabe T
J Clin Oncol 2019 Mar 10;37(8):677-687. Epub 2019 Jan 18 doi: 10.1200/JCO.18.00501. PMID: 30657736 Free PMC Article

Anaplastic Large Cell Lymphoma: Contemporary Concepts and Optimal Management.

Shustov A, Soma L
Cancer Treat Res 2019;176:127-144. doi: 10.1007/978-3-319-99716-2_6. PMID: 30596216

See all (91)

Recent clinical studies

Etiology

New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders.

Quintanilla-Martinez L, Swerdlow SH, Tousseyn T, Barrionuevo C, Nakamura S, Jaffe ES
Virchows Arch 2023 Jan;482(1):227-244. Epub 2022 Oct 11 doi: 10.1007/s00428-022-03414-4. PMID: 36216980 Free PMC Article

T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.

Enteropathy-Associated T cell Lymphoma.

Al Somali Z, Hamadani M, Kharfan-Dabaja M, Sureda A, El Fakih R, Aljurf M
Curr Hematol Malig Rep 2021 Apr;16(2):140-147. Epub 2021 May 19 doi: 10.1007/s11899-021-00634-4. PMID: 34009525

Gastrointestinal non-Hodgkin lymphomas.

Olszewska-Szopa M, Wróbel T
Adv Clin Exp Med 2019 Aug;28(8):1119-1124. doi: 10.17219/acem/94068. PMID: 31414733

Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report.

See all (535)

Diagnosis

New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders.

T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.

Recent Advances in Diagnosis and Therapy of Angioimmunoblastic T Cell Lymphoma.

Mohammed Saleh MF, Kotb A, Abdallah GEM, Muhsen IN, El Fakih R, Aljurf M
Curr Oncol 2021 Dec 20;28(6):5480-5498. doi: 10.3390/curroncol28060456. PMID: 34940095 Free PMC Article

Enteropathy-Associated T cell Lymphoma.

Al Somali Z, Hamadani M, Kharfan-Dabaja M, Sureda A, El Fakih R, Aljurf M
Curr Hematol Malig Rep 2021 Apr;16(2):140-147. Epub 2021 May 19 doi: 10.1007/s11899-021-00634-4. PMID: 34009525

Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma.

Lunning MA, Vose JM
Blood 2017 Mar 2;129(9):1095-1102. Epub 2017 Jan 23 doi: 10.1182/blood-2016-09-692541. PMID: 28115369

See all (692)

Therapy

Epcoritamab: First Approval.

Frampton JE
Drugs 2023 Sep;83(14):1331-1340. doi: 10.1007/s40265-023-01930-4. PMID: 37597091

Update on bi-specific monoclonal antibodies for blood cancers.

Shouse G
Curr Opin Oncol 2023 Sep 1;35(5):441-445. Epub 2023 Jul 5 doi: 10.1097/CCO.0000000000000966. PMID: 37551951

Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study.

Hutchings M, Mous R, Clausen MR, Johnson P, Linton KM, Chamuleau MED, Lewis DJ, Sureda Balari A, Cunningham D, Oliveri RS, Elliott B, DeMarco D, Azaryan A, Chiu C, Li T, Chen KM, Ahmadi T, Lugtenburg PJ
Lancet 2021 Sep 25;398(10306):1157-1169. Epub 2021 Sep 8 doi: 10.1016/S0140-6736(21)00889-8. PMID: 34508654

Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report.

Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma.

Lunning MA, Vose JM
Blood 2017 Mar 2;129(9):1095-1102. Epub 2017 Jan 23 doi: 10.1182/blood-2016-09-692541. PMID: 28115369

See all (358)

Prognosis

CAR T-Cell therapy for the management of mantle cell lymphoma.

Huang Z, Chavda VP, Bezbaruah R, Dhamne H, Yang DH, Zhao HB
Mol Cancer 2023 Mar 31;22(1):67. doi: 10.1186/s12943-023-01755-5. PMID: 37004047 Free PMC Article

New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders.

Recent Advances in Diagnosis and Therapy of Angioimmunoblastic T Cell Lymphoma.

Mohammed Saleh MF, Kotb A, Abdallah GEM, Muhsen IN, El Fakih R, Aljurf M
Curr Oncol 2021 Dec 20;28(6):5480-5498. doi: 10.3390/curroncol28060456. PMID: 34940095 Free PMC Article

Enteropathy-Associated T cell Lymphoma.

Al Somali Z, Hamadani M, Kharfan-Dabaja M, Sureda A, El Fakih R, Aljurf M
Curr Hematol Malig Rep 2021 Apr;16(2):140-147. Epub 2021 May 19 doi: 10.1007/s11899-021-00634-4. PMID: 34009525

Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report.

See all (539)

Clinical prediction guides

Celiac Disease Is a Risk Factor for Mature T and NK Cell Lymphoma: A Mendelian Randomization Study.

Martín-Masot R, Herrador-López M, Navas-López VM, Carmona FD, Nestares T, Bossini-Castillo L
Int J Mol Sci 2023 Apr 13;24(8) doi: 10.3390/ijms24087216. PMID: 37108375 Free PMC Article

Genomic profiling for clinical decision making in lymphoid neoplasms.

de Leval L, Alizadeh AA, Bergsagel PL, Campo E, Davies A, Dogan A, Fitzgibbon J, Horwitz SM, Melnick AM, Morice WG, Morin RD, Nadel B, Pileri SA, Rosenquist R, Rossi D, Salaverria I, Steidl C, Treon SP, Zelenetz AD, Advani RH, Allen CE, Ansell SM, Chan WC, Cook JR, Cook LB, d'Amore F, Dirnhofer S, Dreyling M, Dunleavy K, Feldman AL, Fend F, Gaulard P, Ghia P, Gribben JG, Hermine O, Hodson DJ, Hsi ED, Inghirami G, Jaffe ES, Karube K, Kataoka K, Klapper W, Kim WS, King RL, Ko YH, LaCasce AS, Lenz G, Martin-Subero JI, Piris MA, Pittaluga S, Pasqualucci L, Quintanilla-Martinez L, Rodig SJ, Rosenwald A, Salles GA, San-Miguel J, Savage KJ, Sehn LH, Semenzato G, Staudt LM, Swerdlow SH, Tam CS, Trotman J, Vose JM, Weigert O, Wilson WH, Winter JN, Wu CJ, Zinzani PL, Zucca E, Bagg A, Scott DW
Blood 2022 Nov 24;140(21):2193-2227. doi: 10.1182/blood.2022015854. PMID: 36001803 Free PMC Article

Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study.

Anaplastic Large Cell Lymphoma: Contemporary Concepts and Optimal Management.

Shustov A, Soma L
Cancer Treat Res 2019;176:127-144. doi: 10.1007/978-3-319-99716-2_6. PMID: 30596216

Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia.

Kantarjian HM, O'Brien S, Smith TL, Cortes J, Giles FJ, Beran M, Pierce S, Huh Y, Andreeff M, Koller C, Ha CS, Keating MJ, Murphy S, Freireich EJ
J Clin Oncol 2000 Feb;18(3):547-61. doi: 10.1200/JCO.2000.18.3.547. PMID: 10653870

See all (430)

Recent systematic reviews

Systematic review of survival outcomes for relapsed or refractory adult T-cell leukemia-lymphoma.

Nosaka K, Crawford B, Yi J, Kuan W, Matsumoto T, Takahashi T
Eur J Haematol 2022 Mar;108(3):212-222. Epub 2021 Dec 8 doi: 10.1111/ejh.13728. PMID: 34862665 Free PMC Article

Mogamulizumab for Previously Treated Mycosis Fungoides and Sézary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Grimm SE, Witlox W, Wolff R, Chalker A, Hiligsmann M, Wijnen B, Ahmadu C, Ryder S, Armstrong N, Duffy S, Syndikus I, Kleijnen J, Joore MA
Pharmacoeconomics 2022 May;40(5):509-518. Epub 2021 Oct 19 doi: 10.1007/s40273-021-01098-3. PMID: 34664200 Free PMC Article

Advances and Perspectives in the Treatment of T-PLL.

Braun T, von Jan J, Wahnschaffe L, Herling M
Curr Hematol Malig Rep 2020 Apr;15(2):113-124. doi: 10.1007/s11899-020-00566-5. PMID: 32034661 Free PMC Article

Evolving Strategies for the Treatment of T-Cell Lymphoma: A Systematic Review and Recent Patents.

Laribi K, Alani M, Truong C, de Materre AB
Recent Pat Anticancer Drug Discov 2018;13(3):308-340. doi: 10.2174/1574892813666180517102801. PMID: 29769011

Allogeneic stem-cell transplantation for peripheral T-cell lymphoma: a systemic review and meta-analysis.

Wei J, Xu J, Cao Y, Zhou J, Zhang Y
Acta Haematol 2015;133(2):136-44. Epub 2014 Sep 20 doi: 10.1159/000358579. PMID: 25247746

See all (7)

MedGen

National Center for Biotechnology Information

Send to:

Mature T-cell and NK-cell non-Hodgkin lymphoma

Definition

Term Hierarchy

Professional guidelines

PubMed

Recent clinical studies

Etiology

Diagnosis

Therapy

Prognosis

Clinical prediction guides

Recent systematic reviews

Supplemental Content

Table of contents

Clinical resources

Practice guidelines

Consumer resources

Reviews

Related information

Recent activity